WO2011050871A1 - Verwendung von menthylethern als antibakterielle, antimycotische oder antivirale wirkstoffe - Google Patents
Verwendung von menthylethern als antibakterielle, antimycotische oder antivirale wirkstoffe Download PDFInfo
- Publication number
- WO2011050871A1 WO2011050871A1 PCT/EP2010/004556 EP2010004556W WO2011050871A1 WO 2011050871 A1 WO2011050871 A1 WO 2011050871A1 EP 2010004556 W EP2010004556 W EP 2010004556W WO 2011050871 A1 WO2011050871 A1 WO 2011050871A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic
- substances
- skin
- menthyl
- bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
- A61K2800/874—Roll-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- Bacteria belong to the prokaryotic unicellular organisms. They can be roughly distinguished according to their shape (sphere, cylinder, curved cylinder) and the structure of their cell wall (gram-positive, gram-negative). Finer subdivisions also take into account the physiology of the organisms. There are aerobic, anaerobic and facultative anaerobic bacteria. Some individuals are of medical importance in their capacity as pathogenic agents, while others are completely harmless.
- body odor can also be masked by fragrances, a method that is least in line with the consumer's aesthetic needs, as the mixture of body odor and perfume smells rather unpleasant.
- viruses are biological structures that require a host cell for biosynthesis.
- Extracellular viruses also called “virions” consist of a single- or double-stranded nucleic acid sequence (DNA or RNA) and a protein coat (called capsid), optionally surrounded by an additional lipid-containing envelope (Envelope).
- the classification of the viruses was classed according to clinical criteria, but nowadays mostly according to their structure, their morphology, but in particular according to the nucleic acid sequence.
- Viruses of dermatological importance are, for example, herpes viruses (herpes simplex type 1 and 2, varicella zoster) and papillomaviruses.
- the individual active ingredients used according to the invention can prevent spoilage of organic substances, in particular cosmetic and dermatological preparations, by infestation with Gram-positive and Gram-negative bacteria, mycobionts and viruses when added to these preparations.
- the menthyl esters used in accordance with the invention are preferably used in cosmetic or dermatological compositions in a content of 0.005-50.0% by weight, in particular 0.01-20.0% by weight, based on the total weight of the composition.
- the compositions advantageously contain 0.02-10.0% by weight, more preferably 0.02-5.0% by weight, of one or more menthyl esters used in accordance with the invention, very particularly preferably 0.3-3.0% by weight. %, in each case based on the total weight of the composition.
- Cosmetic preparations which are a shampoo or a washing, shower or bath preparation preferably comprise at least one anionic, nonionic or amphoteric surfactant or mixtures thereof, at least one dialkyl substituted carboxylic acid in the aqueous medium and adjuvants conventionally used therefor ,
- the following examples are intended to illustrate the embodiments of the present inventions. The information always refers to weight%, unless otherwise stated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112012009730-0A BR112012009730A2 (pt) | 2009-10-27 | 2010-07-26 | emprego de mentiláteres como substâncias ativas antibacterianas, antimicóticas ou antivirais |
EP10737518A EP2493463A1 (de) | 2009-10-27 | 2010-07-26 | Verwendung von menthylethern als antibakterielle, antimycotische oder antivirale wirkstoffe |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009050854.6 | 2009-10-27 | ||
DE102009050854A DE102009050854A1 (de) | 2009-10-27 | 2009-10-27 | Verwendung von Menthylethern als antibakterielle, antimycotische oder antivirale Wirkstoffe |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011050871A1 true WO2011050871A1 (de) | 2011-05-05 |
Family
ID=42666312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/004556 WO2011050871A1 (de) | 2009-10-27 | 2010-07-26 | Verwendung von menthylethern als antibakterielle, antimycotische oder antivirale wirkstoffe |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2493463A1 (de) |
BR (1) | BR112012009730A2 (de) |
DE (1) | DE102009050854A1 (de) |
WO (1) | WO2011050871A1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013002421A1 (en) * | 2011-06-30 | 2013-01-03 | Takasago International Corporation | Antimicrobial composition |
WO2013167220A1 (de) * | 2012-05-08 | 2013-11-14 | Merck Patent Gmbh | Verwendung von cyclohexanolethers mit antimikrobiellen eigenschaften |
WO2013091775A3 (de) * | 2011-12-21 | 2013-12-27 | Merck Patent Gmbh | Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007186465A (ja) * | 2006-01-16 | 2007-07-26 | Mandom Corp | 腋臭菌用抗菌剤、並びに該抗菌剤を含有する腋臭防止剤及び皮膚外用剤 |
EP2014273A1 (de) * | 2007-06-14 | 2009-01-14 | Symrise GmbH & Co. KG | Verwendung von Menthylmethylether und weiterer Ether zum Erzeugen eines Sauberkeits- und/oder Reinlichkeitsgefühls |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1289361B1 (de) * | 2000-06-12 | 2005-06-01 | Symrise GmbH & Co. KG | Nichttoxische beschichtungszusammensetzung, verwendungsverfahren und gegen die anlagerung von biofouling-organismen behandelte gegenstände |
JP2004018470A (ja) * | 2002-06-18 | 2004-01-22 | Takasago Internatl Corp | 抗菌香料組成物および口臭抑制香料組成物ならびにそれらを含有する口腔用組成物 |
DE102005002644A1 (de) * | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung |
JP4294640B2 (ja) * | 2005-12-15 | 2009-07-15 | 株式会社マンダム | 防腐殺菌剤、該防腐殺菌剤を配合した化粧品又は医薬品、及び防腐殺菌方法 |
-
2009
- 2009-10-27 DE DE102009050854A patent/DE102009050854A1/de not_active Ceased
-
2010
- 2010-07-26 EP EP10737518A patent/EP2493463A1/de not_active Ceased
- 2010-07-26 BR BR112012009730-0A patent/BR112012009730A2/pt not_active Application Discontinuation
- 2010-07-26 WO PCT/EP2010/004556 patent/WO2011050871A1/de active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007186465A (ja) * | 2006-01-16 | 2007-07-26 | Mandom Corp | 腋臭菌用抗菌剤、並びに該抗菌剤を含有する腋臭防止剤及び皮膚外用剤 |
EP2014273A1 (de) * | 2007-06-14 | 2009-01-14 | Symrise GmbH & Co. KG | Verwendung von Menthylmethylether und weiterer Ether zum Erzeugen eines Sauberkeits- und/oder Reinlichkeitsgefühls |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013002421A1 (en) * | 2011-06-30 | 2013-01-03 | Takasago International Corporation | Antimicrobial composition |
JP2013014521A (ja) * | 2011-06-30 | 2013-01-24 | Takasago Internatl Corp | 抗菌剤組成物 |
CN103732060A (zh) * | 2011-06-30 | 2014-04-16 | 高砂香料工业株式会社 | 抗微生物组合物 |
EP2725900A4 (de) * | 2011-06-30 | 2015-08-05 | Takasago Perfumery Co Ltd | Antimikrobielle zusammensetzung |
CN103732060B (zh) * | 2011-06-30 | 2016-02-17 | 高砂香料工业株式会社 | 抗微生物组合物 |
WO2013091775A3 (de) * | 2011-12-21 | 2013-12-27 | Merck Patent Gmbh | Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe |
US9492364B2 (en) | 2011-12-21 | 2016-11-15 | Merck Patent Gmbh | Use of cyclohexanol derivatives as antimicrobial active compounds |
USRE46698E1 (en) | 2011-12-21 | 2018-02-06 | Merck Patent Gmbh | Use of cyclohexanol derivatives as antimicrobial active compounds |
US10071037B2 (en) | 2011-12-21 | 2018-09-11 | Merck Patent Gmbh | Use of cyclohexanol derivatives as antimicrobial active compounds |
WO2013167220A1 (de) * | 2012-05-08 | 2013-11-14 | Merck Patent Gmbh | Verwendung von cyclohexanolethers mit antimikrobiellen eigenschaften |
JP2015515997A (ja) * | 2012-05-08 | 2015-06-04 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 抗微生物特性を有するシクロヘキサノールエーテルの使用 |
Also Published As
Publication number | Publication date |
---|---|
BR112012009730A2 (pt) | 2020-08-18 |
EP2493463A1 (de) | 2012-09-05 |
DE102009050854A1 (de) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102010007958A1 (de) | Wirkstoffkombinationen aus Acylarginaten und quaternären Ammoniumverbindungen | |
WO2011038797A1 (de) | Verwendung von magnolol oder honokiol als antibakterielle, antimycotische, antiparasitäre oder antivirale wirkstoffe | |
EP0821948A2 (de) | Gegen Bakterien, Mycota und viren wirksame Wirkstoffkombinationen auf der Basis von Partialglyceriden und dialkyl-substituierten Essigsäuren | |
EP2793820B1 (de) | Verwendung einer wirkstoffkombination aus sorbinsäure und einer hydroxamsäure zur bekämpfung von kopfschuppen. | |
EP1157687B1 (de) | Kombinationen von Glycerinmonoalkylethern und Aryl-substituierten Alkoholen | |
EP1461004B1 (de) | Gegen bakterien, mycota und viren wirksame wirkstoffkombinationen auf der basis von dialkylsubstituierten essigsäuren und glycerinalkylethern | |
WO2011050871A1 (de) | Verwendung von menthylethern als antibakterielle, antimycotische oder antivirale wirkstoffe | |
EP2535040B1 (de) | Wirkstoffkombinationen aus (Epsilon-Polylysin und einem oder mehreren ethoxylierten und/oder propoxylierten Alkanolen | |
DE102011088944A1 (de) | Wirkstoffkombinationen aus Silberverbindungen und einer oder mehreren physiologisch unbedenklichen Hydroxamsäure sowie kosmetische oder dermatologischeZubereitungen, solche Wirkstoffkombinationen enthaltend | |
EP1297829A1 (de) | Gegen Bakterien, Mycota und Viren wirksame Wirkstoffkombinationen auf der Basis von mehrwertigen Alkoholen und dialkylsubstituierten Essigsäuren | |
WO2013092404A2 (de) | Wirkstoffkombinationen aus pirocton olamin und einer oder mehreren physiologisch unbedenklichen hydroxamsäure sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend | |
WO2012167936A2 (de) | WIRKSTOFFKOMBINATIONEN AUS ε-POLYLYSIN (EPSILON-POLYLYSIN) UND EINEM ODER MEHREREN TERPENEN | |
EP2717837B1 (de) | Wirkstoffkombinationen aus -polylysin (epsilon-polylysin) und einem oder mehreren aromatischen estern, aldehyden und/oder alkoholen | |
WO2013092424A2 (de) | Wirkstoffkombinationen aus einem oder mehreren polyolen und einer oder mehreren physiologisch unbedenklichen hydroxamsäuren, sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend | |
EP2793814B1 (de) | Wirkstoffkombinationen aus einer oder mehreren aromatischen alkoholen und octanohydroxamsäure sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend | |
EP2793815B1 (de) | Verwendung von dermatologischen zubereitung umfassend eine wirkstoffkombinationen aus einer oder mehreren alkylethern des glycerins und einer oder mehreren physiologisch unbedenklichen hydroxamsäuren | |
DE102011077067A1 (de) | Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem odermehreren aromatischen Aldehyden | |
DE102011077075A1 (de) | Wirkstoffkombinationen aus Epsilon-Polylysin und einem oder mehreren Alkylglucosiden | |
DE102011077063A1 (de) | Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem oder mehrerenaromatischen Alkoholen | |
DE102011077055A1 (de) | Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem oder mehreren aromatischen Estern | |
DE102011077077A1 (de) | Wirkstoffkombinationen aus Epsilon-Polylysin und einem odermehreren Terpenen | |
DE10323703A1 (de) | Mikrobizide Zubereitungen und ihre Verwendung | |
DE102011077070A1 (de) | Wirkstoffkombinationen aus Epsilon-Polylysin und einem oder mehreren Estern mit Terpenstruktur | |
DE19535948A1 (de) | Gegen Bakterien, Mycota und Viren wirksame kosmetische Zubereitungen enthaltend Alkin-, Alkadiin-, und/oder Alkatriincarbonsäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10737518 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010737518 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012009730 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012009730 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120426 |